EDAP TMS SA (FOCL) shareholders
Close on Nov 17, 2026Market cap $106.58MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Soleus Capital Management, L.P. Joint filing with Soleus GP, LLC (19.70%), Guy Levy (19.70%) and 3 more | 7,309,254 | 19.70% | 13G (passive) amendment | Sep 30, 2024 |
| Guy Levy Joint filing with Soleus Capital Master Fund, L.P. (15.80%), Soleus Capital, LLC (15.80%) and 1 more | 7,226,341 | 19.60% | 13G (passive) amendment | Dec 31, 2023 |
| Orin Hirschman Joint filing with AIGH Capital Management LLC (7.60%) | 3,486,246 | 7.60% | 13G (passive) | Sep 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of FOCL | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Soleus Capital Management, L.P. | 7,309,254 | 19.48% | $37.86M | – | 1.30% |
| Morgan Stanley | 3,336,872 | 8.89% | $17.28M | −8,408 | 0.00% |
| Flax Pond Capital, LLC | 1,525,676 | 4.07% | $6.75M | +742,230 | 2.50% |
| Rock Springs Capital Management LP | 1,386,000 | 3.69% | $7.18M | +8,000 | 0.35% |
| Bruce & Co., Inc. | 438,652 | 1.17% | $2.27M | – | 0.61% |
| Parkman Healthcare Partners LLC | 154,832 | 0.41% | $802.03K | – | 0.08% |
| Essex Investment Management Co LLC | 146,005 | 0.39% | $756.31K | New | 0.10% |
| Cahill Financial Advisors Inc | 134,960 | 0.36% | $699.09K | – | 0.07% |
| US Bancorp \de\ | 122,500 | 0.33% | $634.55K | +3,500 | 0.00% |
| UBS Group AG | 118,395 | 0.32% | $613.29K | −51,235 | 0.00% |
| Sage Mountain Advisors LLC | 100,000 | 0.27% | $518.00K | – | 0.03% |
| Leonteq Securities AG | 94,990 | 0.25% | $492.05K | – | 0.02% |
| Summit Trail Advisors, LLC | 82,339 | 0.22% | $426.52K | −20,000 | 0.01% |
| Cetera Investment Advisers | 74,012 | 0.20% | $383.38K | – | 0.00% |
| Commonwealth Equity Services, LLC | 69,160 | 0.18% | $358.25K | – | 0.00% |
| Citadel Advisors LLC | 66,183 | 0.18% | $342.83K | New | 0.00% |
| Legato Capital Management LLC | 48,269 | 0.13% | $250.03K | New | 0.02% |
| Osaic Holdings, Inc. | 42,700 | 0.11% | $221.19K | – | 0.00% |
| Schonfeld Strategic Advisors LLC | 41,730 | 0.11% | $216.16K | +15,869 | 0.00% |
| Manatuck Hill Partners, LLC | 27,597 | 0.07% | $142.95K | – | 0.05% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 37 | 16M | 41.5% | 6 / 9 | 5 / 5 | 1M | 0M |
| Q1 2026 | 36 | 15M | 38.8% | 6 / 5 | 6 / 2 | 0M | 0M |
| Q4 2025 | 33 | 15M | 38.9% | 4 / 2 | 9 / 5 | 1M | 0M |
| Q3 2025 | 34 | 14M | 36.8% | 1 / 3 | 9 / 3 | 0M | 0M |
| Q2 2025 | 36 | 14M | 37.6% | 7 / 2 | 5 / 5 | 0M | 1M |
| Q1 2025 | 34 | 15M | 39.2% | 5 / 5 | 7 / 6 | 0M | 1M |
| Q4 2024 | 35 | 15M | 41.1% | 6 / 7 | 12 / 5 | 0M | 1M |
| Q3 2024 | 34 | 16M | 41.8% | 6 / 8 | 7 / 6 | 0M | 1M |
| Q2 2024 | 35 | 16M | 42.8% | 2 / 7 | 11 / 5 | 0M | 7M |
| Q1 2024 | 38 | 23M | 61.3% | 7 / 9 | 7 / 4 | 4M | 0M |
| Q4 2023 | 35 | 19M | 51.8% | 1 / 10 | 11 / 9 | 5M | 1M |
| Q3 2023 | 43 | 16M | 42.4% | 4 / 11 | 18 / 14 | 1M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
2 funds held FOCL in Q2 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of FOCL | Value | % of fund | As of |
|---|---|---|---|---|---|
| Bruce Fund | 414,794 | 1.11% | $2.15M | 0.57% | Jun 30, 2026 |
| 1290 Essex Small Cap Growth Fund | 124,974 | 0.33% | $764.84K | 0.66% | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 22,764 | 0.06% | $98.57K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ryan Rhodes | Chief Executive Officer, Director | 626,649 | 1.67% | Aug 17, 2026 |
| Steven Annen | SVP, Marketing & Product Mgmt. | 136,490 | 0.36% | Aug 17, 2026 |
| Sanket Shah | General Counsel & Corp Sec | 72,500 | 0.19% | Aug 17, 2026 |
| Kenneth S. Mobeck | Chief Financial Officer | 181,610 | 0.48% | Aug 17, 2026 |
| Francois Mattieu Dietsch | Chief Accounting Officer | 12,000 | 0.03% | Jan 13, 2026 |
| David R. Horn | Director | 10,000 | 0.03% | Aug 17, 2026 |
| Fran Schulz | Director | 15,100 | 0.04% | Aug 17, 2026 |
| Joshua Levine | Director | 45,000 | 0.12% | Aug 17, 2026 |
| Lance Willsey | Director | 1,291,780 | 3.44% | Aug 17, 2026 |
| Glendon E. French III | Director | – | – | Jan 9, 2026 |
| Soleus Capital Master Fund, L.P. | 10% owner | – | – | Aug 20, 2026 |
| Soleus Private Equity Fund III, L.P. | 10% owner | – | – | Aug 20, 2026 |
| Soleus Capital Management, L.P. | 10% owner | – | – | Aug 20, 2026 |
| Soleus Capital Group, LLC | 10% owner | – | – | Aug 20, 2026 |
| Soleus Private Equity GP III, LLC | 10% owner | – | – | Aug 20, 2026 |
| Soleus PE GP III, LLC | 10% owner | – | – | Aug 20, 2026 |
| Soleus Capital, LLC | 10% owner | – | – | Aug 20, 2026 |
| Guy Levy | 10% owner | 1,400,000 | 3.73% | Aug 20, 2026 |
| Soleus GP, LLC | 10% owner | – | – | Aug 20, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Sanket Shah General Counsel & Corp Sec | Aug 14, 2026 | Buy | +5,000 | $4.75 | $23.75K | 72,500 |
| Lance Willsey Director | Aug 14, 2026 | Buy | +50,000 | $4.75 | $237.50K | 1,291,780 |
| Joshua Levine Director | Aug 14, 2026 | Buy | +10,000 | $4.75 | $47.50K | 45,000 |
| Fran Schulz Director | Aug 14, 2026 | Buy | +10,000 | $4.75 | $47.50K | 15,100 |
| Ryan Rhodes Chief Executive Officer, Director | Aug 14, 2026 | Buy | +21,000 | $4.75 | $99.75K | 626,649 |
| David R. Horn Director | Aug 14, 2026 | Buy | +10,000 | $4.75 | $47.50K | 10,000 |
| Kenneth S. Mobeck Chief Financial Officer | Aug 14, 2026 | Buy | +5,000 | $4.75 | $23.75K | 181,610 |
| Steven Annen SVP, Marketing & Product Mgmt. | Aug 14, 2026 | Buy | +5,000 | $4.75 | $23.75K | 136,490 |
| Steven Annen SVP, Marketing & Product Mgmt. | May 12, 2026 | Award | +90,000 | – | – | 131,490 |
| Sanket Shah Gen Counsel & Corp Secretary | May 12, 2026 | Award | +67,500 | – | – | 67,500 |
| Ryan Rhodes Chief Executive Officer, Director | May 12, 2026 | Award | +304,500 | – | – | 605,649 |
| Kenneth S. Mobeck Chief Financial Officer | May 12, 2026 | Award | +120,000 | – | – | 176,610 |
| Joshua Levine Director | May 11, 2026 | Buy | +10,000 | $4.22 | $42.20K | 35,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 5 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Edap Tms's stock actually held short. Settlement fails (shares not delivered on time) peaked at 946 shares on Aug 25, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Lance Willsey Director | Nov 26, 2024 | 30,000 | $74.16K | Nov 26, 2024 | Open Market Purchase |
| Lance Willsey Director | Nov 25, 2024 | 22,702 | $56.74K | Nov 25, 2024 | Open market |
| Lance Willsey Director | Nov 22, 2024 | 11,388 | $29.07K | Nov 22, 2024 | Open Market Purchase |
| Lance Willsey Director | Nov 21, 2024 | 10,000 | $24.84K | Nov 21, 2024 | Open Market Purchase |
| Lance Willsey Director | Nov 20, 2024 | 20,000 | $50.55K | Nov 20, 2024 | Open Market Purchase |
| Lance Willsey Director | Nov 19, 2024 | 15,010 | $36.92K | Nov 19, 2024 | Open Market Purchase |
| Lance Willsey Director | Nov 18, 2024 | 20,000 | $49.41K | Nov 18, 2024 | Open Market Purchase |
| Lance Willsey Director | Nov 15, 2024 | 21,000 | $52.92K | Nov 15, 2024 | Open Market Purchase |
| Lance Willsey Director | Nov 14, 2024 | 10,000 | $25.62K | Nov 14, 2024 | Open Market Purchase |
| Lance Willsey Director | Nov 13, 2024 | 9,900 | $25.52K | Nov 13, 2024 | Open Market Purchase |
See a number that looks wrong?